cisplatin (Q412415)

Gene Ontology release 2019-11-16

cellular response to cisplatin

subject has role

reactant

1 reference

Gene Ontology release 2019-11-16

1 reference

image of molecular model or crystal lattice model

Cisplatin (English)

23 September 2015

Cisplatin-stereo.svg
512 × 310; 5 KB

0 references

Cisplatin-3D-balls.png
1,100 × 914; 229 KB

0 references

CISplatin

subject named as

Cisplatin

1 reference

https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project

2 September 2022

chemical formula

Cl₂H₆N₂Pt

1 reference

medical condition treated

14913-33-8 (English)

27 September 2016

Cl[Pt]([NH3])([NH3])Cl

0 references

isomeric SMILES

Cl[Pt@SP1]([NH3])([NH3])Cl

0 references

lung oat cell carcinoma

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

Hodgkin's lymphoma, mixed cellularity

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

2 references

13 December 2016

subependymal giant cell astrocytoma

2 October 2018

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

transitional cell carcinoma

2 October 2018

1 reference

tongue squamous cell carcinoma

2 October 2018

1 reference

2 October 2018

hepatoblastoma

1 reference

head and neck squamous cell carcinoma

2 October 2018

1 reference

2 October 2018

laryngeal cancer

1 reference

non-small-cell lung carcinoma

2 October 2018

1 reference

2 October 2018

gastric adenocarcinoma

1 reference

2 October 2018

bone sarcoma

1 reference

neuroblastoma, susceptibility to

2 October 2018

1 reference

2 October 2018

19 December 1978

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/Q20Q21Q62J

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018057s083lbl.pdf

ovarian cancer

start time

19 December 1978

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/Q20Q21Q62J

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018057s083lbl.pdf

testicular cancer

start time

19 December 1978

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/Q20Q21Q62J

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018057s083lbl.pdf

significant drug interaction

furosemide

ototoxicity

1 reference

hypothetically

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

nephrotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosphenytoin

peripheral neuropathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenytoin

peripheral neuropathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

ototoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

nephrotoxicity

1 reference

hypothetically

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

kidney failure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

US pregnancy category D

1 reference

English Wikipedia

mass

298.955595 dalton

1 reference

DNA polymerase inhibitors

14913-33-8 (English)

27 September 2016

1 reference

5 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D002945

15 March 2018

cross-linking reagent

1 reference

California Proposition 65 list of chemicals

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

21 February 2020

https://oehha.ca.gov/chemicals/cisplatin

platinum-based antineoplastic

1 reference

27 February 2018

0 references

0 references

Cisplatin

0 references

Identifiers

National Library of Israel J9U ID

987007286296705171

1 reference

National Library of Israel Names and Subjects Authority File

NL CR AUT ID

ph707356

subject named as

cisplatina

0 references

InChI

InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

1 reference

14913-33-8 (English)

27 September 2016

2 references

14913-33-8 (English)

27 September 2016

ChEBI release 2020-09-01

2 references

https://commonchemistry.cas.org/detail?cas_rn=15663-27-1

Cisplatin (English)

23 September 2015

6 April 2021

1 reference

CIS-PLATIN (English)

27 September 2016

azane;dichloroplatinum

2 references

14913-33-8 (English)

27 September 2016

84691

object named as

cis-Diaminodichloroplatinum

1 reference

5460033

1 reference

Gmelin number

2519

0 references

ChEBI ID

27899

mapping relation type

exact match

object named as

cisplatin

2 references

Cisplatin (English)

9 October 2015

International Chemical Identifier

InChI

InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

35852

object named as

transplatin

1 reference

International Chemical Identifier

InChI

InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

1 reference

Cisplatin (English)

9 October 2015

1 reference

789130

1 reference

3789

1 reference

6043

1 reference

1 reference

0 references

1 reference

Russian Wikipedia

RTECS number

TP2450000

1 reference

Russian Wikipedia

ZVG number

490577

1 reference

Hazardous Substances Data Bank

1 reference

28 October 2019

CIS-DIAMINEDICHLOROPLATINUM (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

ECHA Substance Infocard ID

Russian Wikipedia

100.036.106

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

cisplatin (English)

CAS no.: 15663-27-1 (English)

1 reference

Guide to Pharmacology Ligand ID

Cisplatin (English)

publication date

23 September 2015

0 references

Cisplatin

0 references

0 references

0 references

inorganic platinum compound

0 references

1 reference

26 February 2018

1 reference

Human Metabolome Database ID

0 references

2 references

CISPLATIN (English)

9 October 2015

BW0OY6ZTD4

1 reference

MedlinePlus drug identifier

a684036

0 references

PatientsLikeMe treatment ID

0 references

1 reference

CISPLATIN (English)

9 October 2015

0 references

1 reference

Immune Epitope Database and Analysis Resource

Cisplatin (English)

9 October 2015

1 reference

1 March 2022

0 references

Brockhaus Enzyklopädie online ID

0 references

1 reference

California Proposition 65 list of chemicals

2 December 2019